Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
PHASE4
100 participants
INTERVENTIONAL
2021-05-17
2026-05-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pain Management After Surgery
NCT05154682
Patient-Driven Analgesic Protocol Selection for Post-Cesarean Pain Management
NCT02605187
A Multimodal Analgesia Protocol Adapted for Ambulatory Surgery
NCT04015908
Effect of a Multimodal Pain Regimen on Pain Control, Patient Satisfaction and Narcotic Use in Orthopaedic Trauma Patients
NCT02160301
An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service
NCT07296770
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard oral hydrocodone-acetaminophen post-op management
No interventions assigned to this group
Multimodal pain post-op management (Ibuprofen/Acetaminophen/GABAPentin/0.25%Bupivacaine)
Multimodal Pain Management (Ibuprofen/Acetaminophen/GABAPentin/0.25%Bupivacaine)
Multimodal Pain Management to minimize patients' reliance on opioids.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multimodal Pain Management (Ibuprofen/Acetaminophen/GABAPentin/0.25%Bupivacaine)
Multimodal Pain Management to minimize patients' reliance on opioids.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Evaluation and treatment at UCSD
* Age 18years or older
* Ability to understand the content of the patient information/Informed Consent Form
* Signed and dated Institutional Review Board (IRB) approved written informed consent
Exclusion Criteria
* Any not medically managed severe systemic disease
* Their doctor has decided that it is in the patient's best interest to receive pain management regimen of one type vs. the other.
* The patient prefers one type of pain management protocol and is not willing to be randomized.
* Recent history of substance abuse (i.e. recreational drugs, alcohol) that would preclude reliable assessment or confound pain control
* Pregnancy or women planning to conceive within the subject participation period (1 year)
o Pregnancy will be self-reported and no test will be performed to test for it.
* Prisoner
* Participation in any other pharmacologic or medicinal product study within the previous month that could influence the results of this study.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, San Diego
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
William Kent
Assistant Professor of Orthopaedic Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, San Diego
San Diego, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
210031
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.